279 related articles for article (PubMed ID: 26715443)
21. Cefepime as empirical monotherapy in febrile patients with hematological malignancies and neutropenia: a randomized, single-center phase II trial.
Engervall P; Kalin M; Dornbusch K; Björkholm M
J Chemother; 1999 Aug; 11(4):278-86. PubMed ID: 10465130
[TBL] [Abstract][Full Text] [Related]
22. [Analysis of distribution and drug resistance of pathogens of burn patients during 9 years].
Dou Y; Zhang Q
Zhonghua Shao Shang Za Zhi; 2018 Mar; 34(3):153-159. PubMed ID: 29609277
[No Abstract] [Full Text] [Related]
23. Treatment of febrile neutropenia with cefepime monotherapy.
Jándula BM; Martino R; Gurgi M; Manteiga R; Sierra J
Chemotherapy; 2001; 47(3):226-31. PubMed ID: 11306793
[TBL] [Abstract][Full Text] [Related]
24. [Microbiological isolates in patients with febrile neutropenia and hematological neoplasias].
Figuera Esparza M; Carballo M; Silva M; Figueredo A; Avilán J
Rev Esp Quimioter; 2006 Sep; 19(3):247-51. PubMed ID: 17099792
[TBL] [Abstract][Full Text] [Related]
25. An 8-year survey of strains identified in blood cultures in a clinical haematology unit.
Bousquet A; Malfuson JV; Sanmartin N; Konopacki J; MacNab C; Souleau B; de Revel T; Elouennass M; Samson T; Soler C; Foissaud V; Martinaud C
Clin Microbiol Infect; 2014 Jan; 20(1):O7-12. PubMed ID: 23826912
[TBL] [Abstract][Full Text] [Related]
26. Spectrum of systemic bacterial infections during febrile neutropenia in pediatric oncology patients in tertiary care pediatric center.
Siddaiahgari S; Manikyam A; Kumar KA; Rauthan A; Ayyar R
Indian J Cancer; 2014; 51(4):403-5. PubMed ID: 26842136
[TBL] [Abstract][Full Text] [Related]
27. Causative pathogens of fever in neutropenic patients at King Chulalongkorn Memorial Hospital.
Roongpoovapatr P; Suankratay C
J Med Assoc Thai; 2010 Jul; 93(7):776-83. PubMed ID: 20649055
[TBL] [Abstract][Full Text] [Related]
28. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
29. Bacterial isolates in neutropenic febrile patients.
Karim M; Khan W; Farooqi B; Malik I
J Pak Med Assoc; 1991 Feb; 41(2):35-7. PubMed ID: 1902530
[TBL] [Abstract][Full Text] [Related]
30. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].
Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ
Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922
[No Abstract] [Full Text] [Related]
31. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Jones RN; Sader HS; Fritsche TR; Pottumarthy S
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
[TBL] [Abstract][Full Text] [Related]
32. Serious bacterial infections in febrile infants younger than 90 days of age: the importance of ampicillin-resistant pathogens.
Byington CL; Rittichier KK; Bassett KE; Castillo H; Glasgow TS; Daly J; Pavia AT
Pediatrics; 2003 May; 111(5 Pt 1):964-8. PubMed ID: 12728072
[TBL] [Abstract][Full Text] [Related]
33. The relationship between mortality and microbiological parameters in febrile neutropenic patients with hematological malignancies.
Calik S; Ari A; Bilgir O; Cetintepe T; Yis R; Sonmez U; Tosun S
Saudi Med J; 2018 Sep; 39(9):878-885. PubMed ID: 30251730
[TBL] [Abstract][Full Text] [Related]
34. Extended follow-up of an antibiotic cycling program for the management of febrile neutropenia in a hematologic malignancy and hematopoietic cell transplantation unit.
Cumpston A; Craig M; Hamadani M; Abraham J; Hobbs GR; Sarwari AR
Transpl Infect Dis; 2013 Apr; 15(2):142-9. PubMed ID: 23279656
[TBL] [Abstract][Full Text] [Related]
35. Bacteriologic profile and antibiogram of blood culture isolates from a children's hospital in Kabul.
Tariq TM
J Coll Physicians Surg Pak; 2014 Jun; 24(6):396-399. PubMed ID: 24953929
[TBL] [Abstract][Full Text] [Related]
36. [Cefepime as an empiric treatment of febrile neutropenia in patients after high dose therapy and autologous stem cell transplantation].
Zikesoá E; Hnátková M; Vacková B; Jedlicková A; Klener P; Trnený M
Cas Lek Cesk; 2006; 145(5):383-6, 388-9. PubMed ID: 16755776
[TBL] [Abstract][Full Text] [Related]
37. Review of clinical profile and bacterial spectrum and sensitivity patterns of pathogens in febrile neutropenic patients in hematological malignancies: A retrospective analysis from a single center.
Karanwal AB; Parikh BJ; Goswami P; Panchal HP; Parekh BB; Patel KB
Indian J Med Paediatr Oncol; 2013 Apr; 34(2):85-8. PubMed ID: 24049293
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology and source of infection in patients with febrile neutropenia: A ten-year longitudinal study.
Al-Tawfiq JA; Hinedi K; Khairallah H; Saadeh B; Abbasi S; Noureen M; Raza S; Alkhatti A
J Infect Public Health; 2019; 12(3):364-366. PubMed ID: 30594483
[TBL] [Abstract][Full Text] [Related]
39. Frequency of microbial isolates and pattern of antimicrobial resistance in patients with hematological malignancies: a cross-sectional study from Palestine.
Arman G; Zeyad M; Qindah B; Abu Taha A; Amer R; Abutaha S; Koni AA; Zyoud SH
BMC Infect Dis; 2022 Feb; 22(1):146. PubMed ID: 35144553
[TBL] [Abstract][Full Text] [Related]
40. Changes in the microbiological epidemiology of febrile neutropenia in autologous stem cell transplant recipients.
Rönkkö R; Juutilainen A; Koivula I; Vänskä M; Nousiainen T; Jantunen E; Hämäläinen S
Infect Dis (Lond); 2018 Jun; 50(6):436-442. PubMed ID: 29303041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
